References
- Noll R. The encyclopedia of schizophrenia and other psychotic disorders. 3th ed. New York: Infobase Publishing; 2009.
- Kraepelin E. Psychiatry: a textbook for students and physicians. Vol. 1: general psychiatry. Canton, MA: Watson Publishing International; 1899/1990.
- Tamminga CA, Pearlson G, Keshavan M, Sweeney J, Clementz B, Thanker G. Bipolar and schizophrenia network for intermediate phenotypes: outcomes across the psychosis continuum. Schizophr Bull 2014;40:131–7.
- Akabaliev VH, Sivkov ST, Mantarkov MY. Minor physical anomalies in schizophrenia and bipolar I disorder and the neurodevelopmental continuum of psychosis. Bipolar Disord 2014;16:633–41.
- Kalelioglu T, Akkus M, Karamustafalioglu N, Genc A, Genc ES, Cansiz A, et al. Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder. Psychiatry Res 2015;228:925–7.
- Çakır U, Tuman TC, Yıldırım O. Increased neutrophil/lymphoctye ratio in patients with bipolar disorder: a preliminary study. Psychiatr Danub 2015;27:180–4.
- Ivković M, Pantović-Stefanović M, Dunjić-Kostić B, Jurišić V, Lačković M, Totić-Poznanović S, et al. Neutrophil-to-lymphocyte ratio predicting suicide risk in euthymic patients with bipolar disorder: moderatory effect of family history. Compr Psychiatry 2016;66:87–95.
- Kim YK, Jung HG, Myint AM, Kim H, Park SH. Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder. J Affect Disord 2007;104:91–5.
- Ayorech Z, Tracy DK, Baumeister D, Giaroli G. Taking the fuel out of the fire: evidence for the use of anti-inflammatory agents in the treatment of bipolar disorders. J Affect Disord 2015;174:467–78.
- Semiz M, Yildirim O, Canan F, Demir S, Hasbek E, Tuman TC, et al. Elevated neutrophil/lymphocyte ratio in patients with schizophrenia. Psychiatr Danub 2014;26:220–5.
- Fan X, Liu EY, Freudenreich O, Park JH, Liu D, Wang J, et al. Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia. Schizophr Res 2010;118:211–17.
- Zorrilla EP, Cannon TD, Kessler J, Gur RE. Leukocyte differentials predict short-term clinical outcome following antipsychotic treatment in schizophrenia. Biol Psychiatry 1998;43:887–96.
- Fillman SG, Sinclair D, Fung SJ, Webster MJ, Shannon Weickert C. Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl Psychiatry 2014;254:e365.
- Wysokiński A, Margulska A, Strzelecki D, Kloszewska I. Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder. Nord J Psychiatry 2015;69:346–53.
- Cabrera B, Bioque M, Penadés R, González-Pinto A, Parellada M, Bobes J, et al. Cognition and psychopathology in first-episode psychosis: are they related to inflammation? Psychol Med 2016;46:2133–44.
- Avramopoulos D, Pearce BD, McGrath J, Wolyniec P, Wang R, Eckart N, et al. Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation. PLoS One 2015;1710:e0116696.
- Kunz M, Ceresér KM, Goi PD, Fries GR, Teixeira AL, Fernandes BS, et al. Serum levels of IL-6, IL-10 and TNF-α in patients with bipolar disorder and schizophrenia: differences in pro- and anti-inflammatory balance. Rev Bras Psiquiatr 2011;33:268–74.
- Gama CS, Andreazza AC, Kunz M, Berk M, Belmonte-de-Abreu PS, Kapczinski F. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci Lett 2007;420:45–8.
- Mørch RH, Dieset I, Færden A, Hope S, Aas M, Nerhus M, et al. Inflammatory evidence for the psychosis continuum model. Psychoneuroendocrinology 2016;67:189–97.
- Rimol LM, Hartber CB, Nesvag R, Fennema-Notestine C, Hagler DJ, Pung CJ, et al. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol Psychiatry 2010;68:41–50.
- Brandt CL, Eichele T, Melle I, Sundet K, Server A, Agartz I, et al. Working memory networks and activationpatterns in schizophrenia and bipolar disorder: comparison with healthy controls. Br J Psychiatry 2014;204:290–8.
- Simonsen C, Sundet K, Vaskinn A, Birkenaes AB, Engh JA, Faerden A, et al. Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. Schizophr Bull 2011;37:73–83.